Evaluation of Efficacy of Nebulized Low Molecular Weight Heparin as an Adjunctive Extra Treatment for Acute Mild-Moderate Asthma Attack; a Randomized Clinical Trial Study
Publication date: Available online 11 May 2021Source: Pulmonary Pharmacology & TherapeuticsAuthor(s): Hassan Motamed, Mohamadreza Maleki Verki, Ali Vefagh Nematollahi, Saeed Hesam (Source: Pulmonary Pharmacology and Therapeutics)
Source: Pulmonary Pharmacology and Therapeutics - May 12, 2021 Category: Respiratory Medicine Source Type: research

Haemodynamic effects of PAH-targeted therapies in pulmonary hypertension due to lung disease: A systematic review and meta-analysis
Publication date: Available online 9 May 2021Source: Pulmonary Pharmacology & TherapeuticsAuthor(s): Ioannis Farmakis, Polychronis Vazakidis, Ioannis Doundoulakis, Alexandra Arvanitaki, Stefanos Zafeiropoulos, Afroditi Boutou, Haralambos Karvounis, George Giannakoulas (Source: Pulmonary Pharmacology and Therapeutics)
Source: Pulmonary Pharmacology and Therapeutics - May 10, 2021 Category: Respiratory Medicine Source Type: research

Endothelin Antagonism and Sodium Glucose Co-transporter 2 Inhibition A Potential Combination Therapeutic Strategy for COVID-19
Publication date: Available online 30 April 2021Source: Pulmonary Pharmacology & TherapeuticsAuthor(s): Marie Fisk, Magnus Althage, Sven Moosmang, Peter J. Greasley, Andrew P. Cope, David RW. Jayne, James Galloway, Frances Hall, Ian B. Wilkinson, Philip Ambery, Joseph Cheriyan (Source: Pulmonary Pharmacology and Therapeutics)
Source: Pulmonary Pharmacology and Therapeutics - April 30, 2021 Category: Respiratory Medicine Source Type: research

Treatment of Pulmonary Hypertension in Patients with Hereditary Hemorrhagic Telangiectasia – a Case Series and Systematic Review
Publication date: Available online 22 April 2021Source: Pulmonary Pharmacology & TherapeuticsAuthor(s): Eric Abston, Stephanie Hon, Josanna Rodriguez, Matt Moll, Michael Lanuti, Harrison W. Farber, Kevin C. Wilson (Source: Pulmonary Pharmacology and Therapeutics)
Source: Pulmonary Pharmacology and Therapeutics - April 23, 2021 Category: Respiratory Medicine Source Type: research

Gentiopicroside ameliorates ovalbumin-induced airway inflammation in a mouse model of allergic asthma via regulating SIRT1/NF-κB signaling pathway
Publication date: Available online 19 April 2021Source: Pulmonary Pharmacology & TherapeuticsAuthor(s): Bo Zou, Yue Fu, Chaofan Cao, Dianzhu Pan, Wei Wang, Lingfei Kong (Source: Pulmonary Pharmacology and Therapeutics)
Source: Pulmonary Pharmacology and Therapeutics - April 21, 2021 Category: Respiratory Medicine Source Type: research

Characteristics of patients with severe asthma who experienced treatment failure with omalizumab
Publication date: June 2021Source: Pulmonary Pharmacology & Therapeutics, Volume 68Author(s): Tomohiro Akaba, Mitsuko Kondo, Fumi Kobayashi, Nahoko Honda, Soshi Muramatsu, Osamitsu Yagi, Kiyoshi Takeyama, Yukako Seo, Manabu Nonaka, Etsuko Tagaya (Source: Pulmonary Pharmacology and Therapeutics)
Source: Pulmonary Pharmacology and Therapeutics - April 21, 2021 Category: Respiratory Medicine Source Type: research

Corrigendum to “Myricetin inhibits TNF-α-induced inflammation in A549 cells via the SIRT1/NF-κB pathway” [Pulm. Pharmacol. Therapeut. 65 (2020) 102000]
Publication date: Available online 15 April 2021Source: Pulmonary Pharmacology & TherapeuticsAuthor(s): Min Chen, Ziyu Chen, Dan Huang, Chaoqun Sun, Jinye Xie, Tingting Chen, Xuanna Zhao, Jiawei Huang, Dongming Li, Bin Wu, Dong Wu (Source: Pulmonary Pharmacology and Therapeutics)
Source: Pulmonary Pharmacology and Therapeutics - April 16, 2021 Category: Respiratory Medicine Source Type: research

The pharmacology of the prostaglandin D2 receptor 2 (DP2) receptor antagonist, fevipiprant
Publication date: Available online 4 April 2021Source: Pulmonary Pharmacology & TherapeuticsAuthor(s): Chris Brightling, Swarupa Kulkarni, Bart N. Lambrecht, David Sandham, Markus Weiss, Pablo Altman (Source: Pulmonary Pharmacology and Therapeutics)
Source: Pulmonary Pharmacology and Therapeutics - April 5, 2021 Category: Respiratory Medicine Source Type: research

Editorial Board
Publication date: April 2021Source: Pulmonary Pharmacology & Therapeutics, Volume 67Author(s): (Source: Pulmonary Pharmacology and Therapeutics)
Source: Pulmonary Pharmacology and Therapeutics - March 31, 2021 Category: Respiratory Medicine Source Type: research

Commercial α1-antitrypsin preparations markedly differ in their potential to inhibit the ATP-induced release of monocytic interleukin-1β
Publication date: Available online 25 March 2021Source: Pulmonary Pharmacology & TherapeuticsAuthor(s): A. Agné, K. Richter, W. Padberg, S. Janciauskiene, V. Grau (Source: Pulmonary Pharmacology and Therapeutics)
Source: Pulmonary Pharmacology and Therapeutics - March 26, 2021 Category: Respiratory Medicine Source Type: research

Pharmacokinetics of mometasone furoate delivered via two dry powder inhalers
Publication date: Available online 23 March 2021Source: Pulmonary Pharmacology & TherapeuticsAuthor(s): Soniya Vaidya, Dominik Ziegler, Ana-Maria Tanase, Ulf Malmqvist, Frank Kanniess, Bettina Hederer, Motoi Hosoe (Source: Pulmonary Pharmacology and Therapeutics)
Source: Pulmonary Pharmacology and Therapeutics - March 24, 2021 Category: Respiratory Medicine Source Type: research

Chrysin prevents lipopolysaccharide-induced acute lung injury in mice by suppressing the IRE1α/TXNIP/NLRP3 pathway
Publication date: Available online 24 March 2021Source: Pulmonary Pharmacology & TherapeuticsAuthor(s): Min Chen, Jie Li, Xiaoling Liu, Zhenrong Song, Sijia Han, Ruizan Shi, Xuanping Zhang (Source: Pulmonary Pharmacology and Therapeutics)
Source: Pulmonary Pharmacology and Therapeutics - March 24, 2021 Category: Respiratory Medicine Source Type: research

Sequential doxycycline and colchicine combination therapy in Covid-19: The salutary effects
Publication date: Available online 14 March 2021Source: Pulmonary Pharmacology & TherapeuticsAuthor(s): Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Naeem Qusty, Natália Cruz-Martins, Gaber El-Saber Batiha (Source: Pulmonary Pharmacology and Therapeutics)
Source: Pulmonary Pharmacology and Therapeutics - March 14, 2021 Category: Respiratory Medicine Source Type: research

Corrigendum to “Use of nintedanib in interstitial lung disease other than idiopathic pulmonary fibrosis: Much caution is warranted” [Pulm. Pharmacol. 66 (2021 Feb) 101987]
Publication date: Available online 6 March 2021Source: Pulmonary Pharmacology & TherapeuticsAuthor(s): Marco Mura (Source: Pulmonary Pharmacology and Therapeutics)
Source: Pulmonary Pharmacology and Therapeutics - March 8, 2021 Category: Respiratory Medicine Source Type: research

Epimedin C modulates the balance between Th9 cells and Treg cells through negative regulation of noncanonical NF-κB pathway and MAPKs activation to inhibit airway inflammation in the ovalbumin–induced murine asthma model
Publication date: Available online 23 February 2021Source: Pulmonary Pharmacology & TherapeuticsAuthor(s): Muhua Huang, Ying Wei, Jingcheng Dong (Source: Pulmonary Pharmacology and Therapeutics)
Source: Pulmonary Pharmacology and Therapeutics - February 24, 2021 Category: Respiratory Medicine Source Type: research

Myricetin inhibits TNF-α-induced inflammation in A549 cells via the SIRT1/NF-κB pathway
Publication date: Available online 16 February 2021Source: Pulmonary Pharmacology & TherapeuticsAuthor(s): Min Chen, Ziyu Chen, Dan Huang, Chaoqun Sun, Jinye Xie, Tingting Chen, Xuanna Zhao, Yujie Huang, Dongming Li, Bin Wu, Dong Wu (Source: Pulmonary Pharmacology and Therapeutics)
Source: Pulmonary Pharmacology and Therapeutics - February 20, 2021 Category: Respiratory Medicine Source Type: research

The role of TRPA1 and TRPV4 channels in bronchoconstriction and plasma extravasation in airways of rats treated with captopril
Publication date: Available online 19 February 2021Source: Pulmonary Pharmacology & TherapeuticsAuthor(s): Janiana Raíza Jentsch Matias de Oliveira, Mayara Alves Amorim, Eunice André (Source: Pulmonary Pharmacology and Therapeutics)
Source: Pulmonary Pharmacology and Therapeutics - February 20, 2021 Category: Respiratory Medicine Source Type: research

Myricetin inhibits TNF-α-induced inflammation in A549 cells via the SIRT1/NF-κB pathway
Publication date: Available online 16 February 2021Source: Pulmonary Pharmacology & TherapeuticsAuthor(s): Min Chen, Ziyu Chen, Dan Huang, Chaoqun Sun, Jinye Xie, Tingting Chen, Xuanna Zhao, Yujie Huang, Dongming Li, Bin Wu, Dong Wu (Source: Pulmonary Pharmacology and Therapeutics)
Source: Pulmonary Pharmacology and Therapeutics - February 17, 2021 Category: Respiratory Medicine Source Type: research

An Overview of the Biology of a Long-Acting Inhaled Treprostinil Prodrug
Publication date: Available online 15 February 2021Source: Pulmonary Pharmacology & TherapeuticsAuthor(s): Richard W. Chapman, Michel R. Corboz, Vladimir S. Malinin, Adam J. Plaunt, Donna M. Konicek, Zhili Li, Walter R. Perkins (Source: Pulmonary Pharmacology and Therapeutics)
Source: Pulmonary Pharmacology and Therapeutics - February 15, 2021 Category: Respiratory Medicine Source Type: research

CXCR1 correlates to poor outcomes of EGFR-TKI against advanced non-small cell lung cancer by activating chemokine and JAK/STAT pathway
Publication date: Available online 11 February 2021Source: Pulmonary Pharmacology & TherapeuticsAuthor(s): Fang Yang, Shuai Zhang, Qingwei Meng, Fengrui Zhou, Bo Pan, Fang Liu, Yan Yu (Source: Pulmonary Pharmacology and Therapeutics)
Source: Pulmonary Pharmacology and Therapeutics - February 12, 2021 Category: Respiratory Medicine Source Type: research

Glucagon-like peptide 1 receptor (GLP-1R) agonist relieved asthmatic airway inflammation via suppression of NLRP3 inflammasome activation in obese asthma mice model
Publication date: Available online 12 February 2021Source: Pulmonary Pharmacology & TherapeuticsAuthor(s): Jung Hur, Ji Young Kang, Young Kyoon Kim, Sook Young Lee, Hwa Young Lee (Source: Pulmonary Pharmacology and Therapeutics)
Source: Pulmonary Pharmacology and Therapeutics - February 12, 2021 Category: Respiratory Medicine Source Type: research

Risk factors associated with increased discontinuation rate of trimethoprim–sulfamethoxazole used as a primary prophylaxis for Pneumocystis pneumonia: A retrospective cohort study
Publication date: Available online 8 February 2021Source: Pulmonary Pharmacology & TherapeuticsAuthor(s): Toshihito Otani, Kakuhiro Yamaguchi, Shinjiro Sakamoto, Yasushi Horimasu, Takeshi Masuda, Shintaro Miyamoto, Taku Nakashima, Hiroshi Iwamoto, Shintaro Hirata, Kazunori Fujitaka, Hironobu Hamada, Eiji Sugiyama, Noboru Hattori (Source: Pulmonary Pharmacology and Therapeutics)
Source: Pulmonary Pharmacology and Therapeutics - February 10, 2021 Category: Respiratory Medicine Source Type: research

Comparison of L-Carnitine and L-Carnitine HCL Salt for Targeted Lung Treatment of Pulmonary Hypertension (PH) as Inhalation Aerosols: Design, Comprehensive Characterization, In Vitro 2D/3D Cell Cultures, and In Vivo MCT-Rat Model of PH
Publication date: Available online 5 February 2021Source: Pulmonary Pharmacology & TherapeuticsAuthor(s): Maria F. Acosta, Priya Muralidhran, Michael D. Abrahamson, Carissa L. Grijalva, Megan Carver, Haiyang Tang, Christina Klinger, Jeffrey R. Fineman, Stephen M. Black, Heidi M. Mansour (Source: Pulmonary Pharmacology and Therapeutics)
Source: Pulmonary Pharmacology and Therapeutics - February 6, 2021 Category: Respiratory Medicine Source Type: research

Editorial Board
Publication date: February 2021Source: Pulmonary Pharmacology & Therapeutics, Volume 66Author(s): (Source: Pulmonary Pharmacology and Therapeutics)
Source: Pulmonary Pharmacology and Therapeutics - January 28, 2021 Category: Respiratory Medicine Source Type: research

Antihistamines and azithromycin as a treatment for COVID-19 on primary health care – A retrospective observational study in elderly patients
Publication date: Available online 16 January 2021Source: Pulmonary Pharmacology & TherapeuticsAuthor(s): Juan Ignacio Morán Blanco, Judith A. Alvarenga Bonilla, Sakae Homma, Kazuo Suzuki, Philip Fremont-Smith, Karina Villar Gómez de las Heras (Source: Pulmonary Pharmacology and Therapeutics)
Source: Pulmonary Pharmacology and Therapeutics - January 17, 2021 Category: Respiratory Medicine Source Type: research

Tanshinone-IIA inhibits the inflammatory response and proliferation of PAECs under hypoxic conditions by repressing HMGB1 via the TLR4/NF-κB signalling pathway
Publication date: Available online 16 January 2021Source: Pulmonary Pharmacology & TherapeuticsAuthor(s): Dai-Yan Fu, Hua-Ying Lou, Rui-Cheng Hu, Chun-Chu Kong, Yun-Rong Chen, Li- Le Wang, Bin-Bin Chen, Ai-Guo Dai (Source: Pulmonary Pharmacology and Therapeutics)
Source: Pulmonary Pharmacology and Therapeutics - January 17, 2021 Category: Respiratory Medicine Source Type: research

TPMT and HLA-DQA1-HLA-DRB genetic profiling to guide the use of azathioprine in the treatment of interstitial lung disease: first experience
Publication date: Available online 3 January 2021Source: Pulmonary Pharmacology & TherapeuticsAuthor(s): Nada Taha, Karishma Hosein, Amanda Grant-Orser, Ammy Lin-Shaw, Marco Mura (Source: Pulmonary Pharmacology and Therapeutics)
Source: Pulmonary Pharmacology and Therapeutics - January 4, 2021 Category: Respiratory Medicine Source Type: research

Use of nintedanib in interstitial lung disease other than idiopathic pulmonary fibrosis: much caution is warranted
Publication date: Available online 30 December 2020Source: Pulmonary Pharmacology & TherapeuticsAuthor(s): Marco Mura (Source: Pulmonary Pharmacology and Therapeutics)
Source: Pulmonary Pharmacology and Therapeutics - December 31, 2020 Category: Respiratory Medicine Source Type: research

Evaluation of the combination of endothelin receptor antagonists (ERA) and phosphodiesterase-5 inhibitors for the treatment of pulmonary arterial hypertension (PAH) in pathologic human pulmonary arteries in an ex-vivo organ bath model
Publication date: February 2021Source: Pulmonary Pharmacology & Therapeutics, Volume 66Author(s): L. Englert, C. Stadlbauer, M. Spaeth, H.S. Hofmann, C. Schneider, R.A. Hatz, G. Preissler, S. Michel, S. Golovchenko, M. Ried, M. Hoenicka (Source: Pulmonary Pharmacology and Therapeutics)
Source: Pulmonary Pharmacology and Therapeutics - December 24, 2020 Category: Respiratory Medicine Source Type: research

Treprostinil palmitil, an inhaled long-acting pulmonary vasodilator, does not show tachyphylaxis with daily dosing in rats
Publication date: Available online 17 December 2020Source: Pulmonary Pharmacology & TherapeuticsAuthor(s): Richard W. Chapman, Zhili Li, Donald Chun, Helena Gauani, Vladimir Malinin, Adam J. Plaunt, David Cipolla, Walter R. Perkins, Michel R. Corboz (Source: Pulmonary Pharmacology and Therapeutics)
Source: Pulmonary Pharmacology and Therapeutics - December 18, 2020 Category: Respiratory Medicine Source Type: research

Efficacy and safety of inhaled nebulized sodium nitrite in asthmatic patients
Publication date: Available online 15 December 2020Source: Pulmonary Pharmacology & TherapeuticsAuthor(s): Tidarat Sriboonyong, Theerasuk Kawamatawong, Thanaporn Sriwantana, Sirada Srihirun, Varin Titapiwatanakun, Pornpun Vivithanaporn, Prapaporn Pornsuriyasak, Nathawut Sibmooh, Harutai Kamalaporn (Source: Pulmonary Pharmacology and Therapeutics)
Source: Pulmonary Pharmacology and Therapeutics - December 16, 2020 Category: Respiratory Medicine Source Type: research

Aerosolized Beractant in Neonatal Respiratory Distress Syndrome: A Randomized Fixed-Dose Parallel-Arm Phase II Trial
Publication date: Available online 16 December 2020Source: Pulmonary Pharmacology & TherapeuticsAuthor(s): Beena G. Sood, Ronald Thomas, Virginia Delaney-Black, Yuemin Xin, Amit Sharma, Xinguang Chen (Source: Pulmonary Pharmacology and Therapeutics)
Source: Pulmonary Pharmacology and Therapeutics - December 16, 2020 Category: Respiratory Medicine Source Type: research

Editorial Board
Publication date: October 2020Source: Pulmonary Pharmacology & Therapeutics, Volume 64Author(s): (Source: Pulmonary Pharmacology and Therapeutics)
Source: Pulmonary Pharmacology and Therapeutics - December 10, 2020 Category: Respiratory Medicine Source Type: research

Scope of adjuvant therapy using roflumilast, a PDE-4 inhibitor against COVID-19
Publication date: Available online 28 November 2020Source: Pulmonary Pharmacology & TherapeuticsAuthor(s): Sugin Lal Jabaris S, Ranju V (Source: Pulmonary Pharmacology and Therapeutics)
Source: Pulmonary Pharmacology and Therapeutics - November 30, 2020 Category: Respiratory Medicine Source Type: research

An Expert Panel Delphi Consensus Statement on Patient Selection and Management for Transitioning Between Oral and Inhaled Treprostinil
Publication date: Available online 28 November 2020Source: Pulmonary Pharmacology & TherapeuticsAuthor(s): Franck F. Rahaghi, Roblee P. Allen, Vijay P. Balasubramanian, Murali M. Chakinala, Jean M. Elwing, Jeremy Feldman, Peter J. Leary, Franz Rischard, Zeenat Safdar, Namita Sood, Ronald J. Oudiz (Source: Pulmonary Pharmacology and Therapeutics)
Source: Pulmonary Pharmacology and Therapeutics - November 30, 2020 Category: Respiratory Medicine Source Type: research

Investigating the effect of TRPV4 inhibition on pulmonary-vascular barrier permeability following segmental endotoxin challenge
Publication date: Available online 13 November 2020Source: Pulmonary Pharmacology & TherapeuticsAuthor(s): Sarah Mole, Anya Harry, Andy Fowler, Sarah Hotee, Joseph Warburton, Sarah Waite, Misba Beerahee, David J. Behm, Philipp Badorrek, Meike Müller, Cornelia Faulenbach, Aili L. Lazaar, Jens M. Hohlfeld (Source: Pulmonary Pharmacology and Therapeutics)
Source: Pulmonary Pharmacology and Therapeutics - November 13, 2020 Category: Respiratory Medicine Source Type: research

Ethnic pharmacokinetic comparison of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler (BGF MDI) between Asian and Western healthy subjects
Publication date: Available online 2 November 2020Source: Pulmonary Pharmacology & TherapeuticsAuthor(s): Ying Huang, Pryseley Nkouibert Assam, Cong Feng, Rong Su, Paul Dorinsky, Michael Gillen (Source: Pulmonary Pharmacology and Therapeutics)
Source: Pulmonary Pharmacology and Therapeutics - November 4, 2020 Category: Respiratory Medicine Source Type: research

Benralizumab improves patient reported outcomes and functional parameters in difficult-to-treat patients with severe asthma: Data from a real-life cohort
Publication date: Available online 1 November 2020Source: Pulmonary Pharmacology & TherapeuticsAuthor(s): Danilo Di Bona, Elena Minenna, Marcello Albanesi, Eustachio Nettis, Maria Filomena Caiaffa, Luigi Macchia (Source: Pulmonary Pharmacology and Therapeutics)
Source: Pulmonary Pharmacology and Therapeutics - November 2, 2020 Category: Respiratory Medicine Source Type: research

Advanced Spray Dried Proliposomes of Amphotericin B Lung Surfactant-Mimic Phospholipid Microparticles/Nanoparticles as Dry Powder Inhalers for Targeted Pulmonary Drug Delivery
Publication date: Available online 31 October 2020Source: Pulmonary Pharmacology & TherapeuticsAuthor(s): Alexan I. Gomez, Maria F. Acosta, Priya Muralidharan, Jason.X.-J Yuan, Stephen M. Black, Don Hayes, Heidi M. Mansour (Source: Pulmonary Pharmacology and Therapeutics)
Source: Pulmonary Pharmacology and Therapeutics - November 1, 2020 Category: Respiratory Medicine Source Type: research

Using prednisolone and cortisol assays to assess adherence in oral corticosteroid dependant asthma: an analysis of test-retest repeatability
Publication date: Available online 9 October 2020Source: Pulmonary Pharmacology & TherapeuticsAuthor(s): John Busby, Cecile Holweg, Akiko Chai, Peter Bradding, Rekha Chaudhuri, Adel Mansur, John G. Matthews, Andrew Menzies-Gow, James Lordan, Rob Niven, Liam G. Heaney, in collaboration with the UK Refractory Asthma Stratification Programme (RASP-UK) (Source: Pulmonary Pharmacology and Therapeutics)
Source: Pulmonary Pharmacology and Therapeutics - October 11, 2020 Category: Respiratory Medicine Source Type: research

Significant improvement in lung function and asthma control after benralizumab treatment for severe refractory eosinophilic asthma
Publication date: Available online 8 October 2020Source: Pulmonary Pharmacology & TherapeuticsAuthor(s): Francesco Menzella, Patrizia Ruggiero, Carla Galeone, Chiara Scelfo, Diego Bagnasco, Nicola Facciolongo (Source: Pulmonary Pharmacology and Therapeutics)
Source: Pulmonary Pharmacology and Therapeutics - October 10, 2020 Category: Respiratory Medicine Source Type: research

Methacholine-induced cough as an indicator of bronchodilator-responsive cough
Publication date: Available online 8 October 2020Source: Pulmonary Pharmacology & TherapeuticsAuthor(s): Noriyuki Ohkura, Masaki Fujimura, Johsuke Hara, Yusuke Nakade, Miki Abo, Takashi Sone, Hideharu Kimura, Kazuo Kasahara (Source: Pulmonary Pharmacology and Therapeutics)
Source: Pulmonary Pharmacology and Therapeutics - October 10, 2020 Category: Respiratory Medicine Source Type: research

Rapid effect of benralizumab for severe asthma with chronic rhinosinusitis with nasal polyps
Publication date: Available online 9 October 2020Source: Pulmonary Pharmacology & TherapeuticsAuthor(s): Osamu Matsuno, Seijiro Minamoto (Source: Pulmonary Pharmacology and Therapeutics)
Source: Pulmonary Pharmacology and Therapeutics - October 10, 2020 Category: Respiratory Medicine Source Type: research

ORMDL3 modulates airway epithelial cell repair in children with asthma under glucocorticoid treatment via regulating IL-33
Publication date: Available online 6 October 2020Source: Pulmonary Pharmacology & TherapeuticsAuthor(s): Yaqin Li, Xiaoyan Li, Wenjing Zhou, Qing Yu, Yanming Lu (Source: Pulmonary Pharmacology and Therapeutics)
Source: Pulmonary Pharmacology and Therapeutics - October 8, 2020 Category: Respiratory Medicine Source Type: research

Pharmacokinetics of indacaterol, glycopyrronium and mometasone furoate following once-daily inhalation as a combination in healthy subjects
Publication date: Available online 6 October 2020Source: Pulmonary Pharmacology & TherapeuticsAuthor(s): Soniya Vaidya, Juergen Jauernig, Brian Ethell, Nasri Abdallah, Surendra Machineni, Anton Drollmann, Olivier Heudi, Stefanie Last, Michael Hahn, Rajkumar Radhakrishnan, Stanislav Ignatenko, Hanns-Christian Tillmann (Source: Pulmonary Pharmacology and Therapeutics)
Source: Pulmonary Pharmacology and Therapeutics - October 8, 2020 Category: Respiratory Medicine Source Type: research

QA project: Hemodynamic Safety of Endobronchial Administration of Phenylephrine for Control of Airway Bleeding by Bronchoscopy
Publication date: Available online 7 October 2020Source: Pulmonary Pharmacology & TherapeuticsAuthor(s): Nathaniel Ivanick, Chan Yeu Pu (Source: Pulmonary Pharmacology and Therapeutics)
Source: Pulmonary Pharmacology and Therapeutics - October 8, 2020 Category: Respiratory Medicine Source Type: research

Dihydroquercetin attenuates lipopolysaccharide-induced acute lung injury through modulating FOXO3-mediated NF-κB signaling via miR-132–3p
Publication date: October 2020Source: Pulmonary Pharmacology & Therapeutics, Volume 64Author(s): Jian-Hua Liu, Liang Cao, Chang-Hong Zhang, Chen Li, Zhi-Hua Zhang, Qi Wu (Source: Pulmonary Pharmacology and Therapeutics)
Source: Pulmonary Pharmacology and Therapeutics - September 29, 2020 Category: Respiratory Medicine Source Type: research

Editorial Board
Publication date: August 2020Source: Pulmonary Pharmacology & Therapeutics, Volume 63Author(s): (Source: Pulmonary Pharmacology and Therapeutics)
Source: Pulmonary Pharmacology and Therapeutics - September 26, 2020 Category: Respiratory Medicine Source Type: research

Inhalation: A means to explore and optimize nintedanib's pharmacokinetic/pharmacodynamic relationship
Publication date: August 2020Source: Pulmonary Pharmacology & Therapeutics, Volume 63Author(s): Gali Epstein-Shochet, Stephen Pham, Steven Beck, Safaa Naiel, Olivia Mekhael, Spencer Revill, Aaron Hayat, Megan Vierhout, Becky Bardestein-Wald, David Shitrit, Kjetil Ask, A. Bruce Montgomery, Martin R. Kolb, Mark W. Surber (Source: Pulmonary Pharmacology and Therapeutics)
Source: Pulmonary Pharmacology and Therapeutics - September 23, 2020 Category: Respiratory Medicine Source Type: research

Real-life safety and efficacy of omalizumab in Japanese patients with severe allergic asthma who were subjected to dosing table revision or expansion: A post-marketing surveillance
Publication date: Available online 17 September 2020Source: Pulmonary Pharmacology & TherapeuticsAuthor(s): Koichiro Asano, Kazuya Sumi, Hajime Yoshisue, Noriko Nakamura, Makoto Nagasaki, Takayoshi Sasajima, Hisako Matsumoto (Source: Pulmonary Pharmacology and Therapeutics)
Source: Pulmonary Pharmacology and Therapeutics - September 18, 2020 Category: Respiratory Medicine Source Type: research